Chondroid syringoma

From WikiMD's WELLNESSPEDIA

Chondroid syringoma
Histopathology of chondroid syringoma.jpg
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms N/A
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes N/A
Risks N/A
Diagnosis N/A
Differential diagnosis N/A
Prevention N/A
Treatment N/A
Medication N/A
Prognosis N/A
Frequency N/A
Deaths N/A


Chondroid syringoma, also known as a mixed tumor of the skin, is a rare benign skin tumor that arises from the eccrine or apocrine sweat glands. It is characterized by its histological resemblance to pleomorphic adenoma of the salivary gland.

Presentation[edit]

Chondroid syringomas typically present as slow-growing, painless, subcutaneous nodules. They are most commonly found on the head and neck region, particularly on the nose, cheeks, and scalp. These tumors are more frequently observed in middle-aged and older adults, with a slight male predominance.

Histopathology[edit]

The histological examination of chondroid syringoma reveals a biphasic pattern, consisting of both epithelial and mesenchymal components. The epithelial component is composed of tubular and ductal structures, while the mesenchymal component resembles cartilage, hence the name "chondroid." The presence of these two components is what gives the tumor its "mixed" nature.

Diagnosis[edit]

Diagnosis of chondroid syringoma is primarily based on histopathological examination. A biopsy of the lesion is performed, and the characteristic features of the tumor are identified under a microscope. Imaging studies such as ultrasound or MRI may be used to assess the extent of the tumor, especially if it is located in a cosmetically sensitive area.

Treatment[edit]

The treatment of choice for chondroid syringoma is surgical excision. Complete removal of the tumor is necessary to prevent recurrence. Due to its benign nature, the prognosis after surgical excision is excellent, with a low likelihood of recurrence if the tumor is completely removed.

Differential Diagnosis[edit]

The differential diagnosis for chondroid syringoma includes other skin tumors such as:

Also see[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.